FDA Inspection 974714 — Leslie S. Baumann, M.D.

Leslie S. Baumann, M.D. — FEI 3003701843

The FDA completed an inspection of Leslie S. Baumann, M.D. on June 23, 2016 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 23, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)